Browsing Tag
Gland Pharma
Gland Pharma slips 10%, hits 52-week low on disappointing Q1 results
Shares of Gland Pharma hit a 52-week low of Rs 2,232 as they slipped 10 per cent on the BSE in…
Ahead of Market: 10 things that will decide D-Street action on Friday
NEW DELHI: Indian stocks were under pressure for the fourth consecutive day as investors remained cautious with US inflation inching up further in June and the risk of a sharper rate hike by the Federal Reserve. Nifty opened with minor…
Can PLI, China Plus One keep India’s pharma sector in pink of health?
The US economy also witnessed substantial issues in its pharma market. In addition to these, manufacturing & exporting countries around the world saw heightened raw material price inflation followed by supply chain disruption. All these…
12 stocks that are BofA Securities’ top buys from 7 sectors. Do you own them?
NEW DELHI: Foreign brokerage BofA Securities, which had suggested a year-end of 14,500 on Nifty50, said it would maintain a defensive strategy skew, as it raised its overweight stance on staples, healthcare and utilities. The brokerage has…
Global brokerages see up to 115% upside in Tata Steel, Vedanta, Gland Pharma
New Delhi: Despite strong volatility seen in sectors like metal, mining and pharma, global brokerage firms are bullish on select stocks from these pockets.
Global brokerage Citi remains bullish on , maintaining a buy rating on the counter.…
Daljeet Singh Kohli prefers bank to IT stocks now. Here’s why
“Auto stocks are coming closer to our buying zone. We are looking positively and constructively on the sector,” says Daljeet Singh Kohli, CIO, Stockaxis.com
What is your take on private banks? Is there value in the big ones now?We have a…
Jefferies sees up to 21% upside in these two pharma stocks
NEW DELHI: Foreign brokerage Jefferies has initiated coverage on Gland Pharma and with buy ratings. It has a target of Rs 4,566 on Gland Pharma, valuing the stock at 36.5 times FY24 EPS, in line with its historical one-year forward of 37…